LeadingBiotech: Cancer Advance is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Marty Tenenbaum, Ph.D.
Founder and Chairman at Cancer Commons; xCures


Marty Tenenbaum is a renowned computer scientist, Internet entrepreneur and cancer survivor. He founded Cancer Commons, xCures and CollabRx (NASD: CRLX) to arm patients and their physicians with the knowledge they need to achieve the best possible outcomes, and track their results to continuously learn.. Dr. Tenenbaum began his career in AI, leading elite research groups at SRI International and Schlumberger Ltd. Later, as an Internet commerce pioneer, he founded or co-founded five successful startups. He is a fellow and former board member of the American Association for Artificial Intelligence, a former Director of Commerce One, the Public Library of Science (PLoS) and Patients Like Me, and a former consulting professor of Computer Science at Stanford. He currently serves as a Director of CommerceNet and Efficient Finance. Dr. Tenenbaum holds B.S. and M.S. degrees in Electrical Engineering from MIT, and a Ph.D. from Stanford, and has received numerous awards for his contributions to AI and his work as a patient advocate.

Marty Tenenbaum, Ph.D.'s Network

Agenda Sessions

  • Keynote Chat: Reinventing Oncology through AI to Improve Outcomes, Accelerate Learning, and Streamline Drug Development